Maternal inhaled fluticasone propionate intake during pregnancy is detected in neonatal cord blood.

View Abstract

BACKGROUND

Despite recommendations to use inhaled corticosteroids as treatment to control asthma during pregnancy, it is unknown whether inhaled fluticasone propionate (FP) reaches the fetus. Results & methodology: We collected maternal blood on the morning following delivery. FP was detected by ultra-performance LC-MS/MS (UPLC-MS/MS) in 9/17 asthmatic women using FP. Delay between last FP inhalation and maternal blood sampling ranged between 3 and 33 h and FP was detected in a range of 1.572-46.440 pg/ml. Among the nine offspring of these FP users, FP was detected in five cord blood samples. Delay between last predelivery FP inhalation and cord blood sampling ranged from 4 to 20 h and FP was detected in a range of 0.423-4.510 pg/ml.

CONCLUSION

Our findings demonstrate placental passage of inhaled FP.

Investigators
Abbreviation
Bioanalysis
Publication Date
2016-06-28
Pubmed ID
27349687
Medium
Print-Electronic
Full Title
Maternal inhaled fluticasone propionate intake during pregnancy is detected in neonatal cord blood.
Authors
Battista MC, Boutin M, Venne P, Blais L, Bérard A, Lacroix M, Patenaude J, Guillemette L, Cossette B, Hivert MF, Auray-Blais C